To Screen or Not to Screen for Lung Cancer?

A new study in CHEST, a peer-reviewed medical journal covering chest diseases and related issues, determined that a structured prescreening counseling and shared decision-making visit with healthcare professionals leads to a better understanding of the benefits and risks, as well as the eligibility criteria, of lung cancer screening using a low-dose CT scan. This is

American Urological Association, American Society for Radiation Oncology, and the Society of Urologic Oncology Release Joint Prostate Cancer Guidelines

Last week, the American Urological Association (AUA), the American Society for Radiation Oncology (ASTRO), and the Society of Urologic Oncology (SUO) released collaborative clinical guidelines for managing localized prostate cancer which offers a framework for shared decision-making between physicians and patients.  Through this collaboration, the committee provided guidance on active surveillance and on which treatments

Radiosurgery Society Study Examines Stereotactic Body Radiation Therapy Outcomes in the Treatment of Lung Metastases

The Radiosurgery Society (RSS), a non-profit medical society dedicated to advancing the science and clinical practice of radiosurgery, recently published a study using data from its RSSearch Patient Registry, a multi-institutional, observational registry established to standardize data collection from patients treated with stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). The study, titled “Lung

New Jersey CyberKnife lung cancer radio spot

Please take a moment and listen to New Jersey CyberKnife’s new lung cancer radio spot and remember, if you’ve been diagnosed with lung cancer, talk to your doctor about all your treatment options. It’s Your Lungs. Your Cancer. Your Choice.

New Jersey CyberKnife Wins Award of Excellence

New Jersey CyberKnife recently won the Award of Excellence at Alliance Oncology’s 2017 Division Meeting. The annual meeting was held April 12 – 14 at the Sheraton Grand in downtown Nashville, Tennessee. The Award of Excellence is bestowed to the top radiation oncology center in the company and was presented by the Senior Vice President

SBRT Offers Curative Option for Lung Cancer Patients Age 80 and Older

According to research presented at the recent Multidisciplinary Thoracic Cancers Symposium, patients in their eighties and nineties who have early stage lung cancer but cannot undergo an operation can be treated safely and effectively with stereotactic body radiation therapy (SBRT).  The advanced form of radiation therapy was well tolerated among this relatively understudied elderly population,

Understanding Clinical Trials

The future of cancer treatment has never been so promising.  Many advances in cancer treatments are being announced every day and even more treatment options that have the potential to improve the health of cancer patients are currently in development in medical facilities across the country.  As part of the development and approval process, it

SBRT Offers Prostate Cancer Patients High Cancer Control and Low Toxicity in Fewer Treatments

According to research presented at the recent 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO), high dose stereotactic body radiotherapy (SBRT) for men newly-diagnosed with low- or intermediate-risk prostate cancer results in shorter treatment times, low severe toxicity, and excellent cancer control rates.  The Cyberknife at New Jersey Cyberknife delivers SBRT.  Although